Serum Levels of Inflammatory Markers in Neonatal Sepsis
Author Information
Author(s): Kurt A. Nese Citak, Aygun A. Denizmen, Godekmerdan Ahmet, Kurt Abdullah, Dogan Yasar, Yilmaz Erdal
Primary Institution: Firat University
Hypothesis
To determine serum IL-1β, IL-6, IL-8, and TNF-α levels in neonatal sepsis at the time of diagnosis and after therapy.
Conclusion
Serum IL-1β, IL-6, IL-8, and TNF-α are mediators of inflammation and can be used at the diagnosis and at the evaluation of the therapeutic efficiency in neonatal sepsis.
Supporting Evidence
- Serum levels of IL-1β, IL-6, IL-8, and TNF-α were significantly higher in culture-proven sepsis compared to controls.
- Cytokine levels decreased significantly after seven days of antibiotic treatment.
- The study included a total of 50 newborns with varying classifications of sepsis.
Takeaway
Doctors can check certain substances in the blood to help find out if a newborn has a serious infection called sepsis.
Methodology
This prospective study included newborns hospitalized for neonatal sepsis, classified into culture-proven sepsis, culture-negative sepsis, and healthy controls, with blood samples taken at diagnosis and after therapy.
Limitations
The study may have limitations related to sample size and the specificity of the cytokine measurements.
Participant Demographics
The study included 50 newborns: 12 with culture-proven sepsis, 21 with culture-negative sepsis, and 17 healthy controls.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website